Structure and Folding of Proteins with Identical Tandemly Arrayed Domains

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Very recent work from the Clarke lab used single-molecule techniques to detect misfolding events in a synthetic construct containing adjacent domains of the same fold and identical sequence. These misfolding events disappeared when the sequence identity between domains was reduced to ~40%. Many multi-domain proteins contain strings of domains with the same fold and these misfolding events are thus the likely explanation for the apparent evolutionary pressure to maintain sequence diversity in adjacent domains in almost all such proteins.
Very recent work in the Potts lab has solved the structure of a native protein with virtually identical tandemly arrayed domains. In SasG, a Staphylococcus aureus surface protein involved in bacterial biofilm formation, domain identity is driven at the DNA level and appears to be a mechanism facilitating antigenic variation. The protein domains lack the normally expected compact hydrophobic core and we propose this novel structure has evolved to avoid misfolding events when the presence of identical domains is otherwise advantageous. The overall aim of the research is to use SasG to enhance our understanding of how proteins fold and, importantly, how they avoid misfolding.

The specific objectives of the proposed research are to:
1. Identify the sources of thermodynamic stability and to determine the folding mechanism of the single layer beta-sheet SasG domains.
2. Test a number of different SasG constructs for rare misfolding events using a recently-developed single molecule FRET technique. Are specific residues important for resisting misfolding?
3. Understand the role of SasG domains and specific residues in resisting mechanical unfolding.
4. Determine the structure of a different bacterial protein with identical tandemly arrayed domains (to establish if it also has an unusual fold).
5. Lay the groundwork for potential applications of designed SasG constructs of specific length in nanotechnology.

This research proposal seeks to investigate a novel multidomain protein whose structure challenges many of our ideas about how proteins fold and how they avoid misfolding. Our hypothesis is that it is the extraordinary non-globular structure that proteins the proteins against misfolding. SasG, the protein of interest, is one of a series of extra-cellular bacterial proteins that contain nearly identical duplicated repeats. We are also going to investigate the structure of a second such protein where no structural information is available at all.

One of the groups of beneficiaries is the members of the community of protein folding researchers, in particular to those who use computational methods. Our studies of these proteins will allow us to reassess out understanding of how proteins fold. SasG is predicted to be unfolded by most algorithms which predict disorder. Yet it is clearly not. In the "omics" era computational methods have become particularly important in the analysis and of and prediction from the wealth of genomic and structural data. In the fields of bioinformatics and structure prediction, force fields and algorithms are based on experimental data, so studies of novel folds such as that of SasG are essential for furthering our understanding.

The two post docs to be employed on this project are also beneficiaries. The strong collaboration between our two groups, which a different yet complementary set of skills, provides an outstanding opportunity for two young scientists to be trained in world class laboratories. They will then be in an excellent position to continue their career, whether in academia, or very likely, in industry, where there is a real national demand for highly skilled scientists with the skill set we are offering. Of the many students and post-docs to have passed through the Clarke laboratory, for instance, a significant proportion are now employed in the biotechnology industry, some in small start-up companies, and others in companies which have now been taken into the mainstream pharmaceutical industry sector (such as Medimmune).

Although not explicitly a project which aims to have a technological outcome, this project may have some future applications, resulting in some economic or well-being benefits. The proteins we are investigating are involved in biofilm formation. Biofilms are of significant economic importance both in terms of medicine (where they are detrimental as they are involved in bacterial infection) and in the industrial context (where they may be either detrimental or helpful). We are not directly investigating biofilm formation, yet a fundamental understanding of the biophysical and mechanical properties of the proteins which mediate biofilm formation may be valuable to underpin future research in this area. The use of biological molecules in nanotechnology is in its infancy. We will investigate whether SasG, a highly soluble, rigid molecule may be suitable to provide molecules in the nanometre length scale that are tuneable both in terms of size and in terms of sites which can be functionalised.